Search
Compass Pathways PLC
CMPSAdd to Watchlist
13.620USD
+0.330+2.48%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
842.87MMarket Cap
LossP/E TTM
More Details of Compass Pathways PLC Company
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Compass Pathways PLC Info
Ticker SymbolCMPS
Company nameCompass Pathways PLC
IPO dateSep 18, 2020
CEONath (Kabir)
Number of employees166
Security typeDepository Receipt
Fiscal year-endSep 18
Address3Rd Floor, 1 Ashley Road
CityALTRINCHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeWA14 2DT
Phone17166766461
Websitehttps://compasspathways.com/
Ticker SymbolCMPS
IPO dateSep 18, 2020
CEONath (Kabir)
Company Executives of Compass Pathways PLC
Name
Name/Position
Position
Shareholding
Change
Dr. Robert McQuade, Ph.D.
Dr. Robert McQuade, Ph.D.
Independent Director
Independent Director
1.59M
--
Mr. Thomas Lonngren
Mr. Thomas Lonngren
Independent Director
Independent Director
89.05K
--
Mr. Kabir Nath
Mr. Kabir Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
58.19K
-228.13%
Ms. Teri Loxam
Ms. Teri Loxam
Chief Financial Officer
Chief Financial Officer
26.89K
-197.34%
Mr. David Norton
Mr. David Norton
Independent Director
Independent Director
20.36K
--
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Director
Independent Director
19.48K
--
Dr. Guy Goodwin
Dr. Guy Goodwin
Chief Medical Officer
Chief Medical Officer
1.99K
--
Dr. Wayne Joseph Riley, M.D.
Dr. Wayne Joseph Riley, M.D.
Independent Director
Independent Director
--
--
Ms. Daphne Karydas
Ms. Daphne Karydas
Independent Director
Independent Director
--
--
Mr. Gino Santini
Mr. Gino Santini
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Robert McQuade, Ph.D.
Dr. Robert McQuade, Ph.D.
Independent Director
Independent Director
1.59M
--
Mr. Thomas Lonngren
Mr. Thomas Lonngren
Independent Director
Independent Director
89.05K
--
Mr. Kabir Nath
Mr. Kabir Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
58.19K
-228.13%
Ms. Teri Loxam
Ms. Teri Loxam
Chief Financial Officer
Chief Financial Officer
26.89K
-197.34%
Mr. David Norton
Mr. David Norton
Independent Director
Independent Director
20.36K
--
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Director
Independent Director
19.48K
--
FAQs
Who are the top five shareholders of Compass Pathways PLC?
The top five shareholders of Compass Pathways PLC are: Dr. Robert McQuade, Ph.D.
How many institutions hold shares of Compass Pathways PLC (CMPS)?
As of 2026Q1, 313 institutions hold shares of Compass Pathways PLC, with a combined market value of approximately 60.19M, accounting for 44.61% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -22728311.00.